Canada markets close in 3 hours 51 minutes

CK Life Sciences Int'l., (Holdings) Inc. (LSI.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
0.0410+0.0030 (+7.89%)
As of 08:24AM CEST. Market open.
Currency in EUR

Valuation Measures4

Market Cap (intraday) 418.50M
Enterprise Value 1.05B
Trailing P/E 176.96
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.58
Price/Book (mrq)0.73
Enterprise Value/Revenue 0.20
Enterprise Value/EBITDA 1.67

Trading Information

Stock Price History

Beta (5Y Monthly) 0.22
52-Week Change 3-56.32%
S&P500 52-Week Change 324.19%
52 Week High 30.0895
52 Week Low 30.0315
50-Day Moving Average 30.0423
200-Day Moving Average 30.0652

Share Statistics

Avg Vol (3 month) 348
Avg Vol (10 day) 3N/A
Shares Outstanding 59.61B
Implied Shares Outstanding 611.01B
Float 82.4B
% Held by Insiders 174.98%
% Held by Institutions 11.34%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 42.51%
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 41.53
Payout Ratio 4444.44%
Dividend Date 3N/A
Ex-Dividend Date 4May 23, 2023
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in HKD.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.32%
Operating Margin (ttm)3.64%

Management Effectiveness

Return on Assets (ttm)1.24%
Return on Equity (ttm)0.41%

Income Statement

Revenue (ttm)5.32B
Revenue Per Share (ttm)0.55
Quarterly Revenue Growth (yoy)0.30%
Gross Profit (ttm)N/A
EBITDA 380.71M
Net Income Avi to Common (ttm)17.25M
Diluted EPS (ttm)0.0000
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)676.16M
Total Cash Per Share (mrq)0.07
Total Debt (mrq)5.93B
Total Debt/Equity (mrq)141.58%
Current Ratio (mrq)1.42
Book Value Per Share (mrq)0.44

Cash Flow Statement

Operating Cash Flow (ttm)514.18M
Levered Free Cash Flow (ttm)57.61M